Eaton Vance Management Homology Medicines, Inc. Transaction History

Eaton Vance Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$2.6 - $4.17 $325 - $521	-125 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$3.64 - $7.78 $2,912 - $6,224	-800 Reduced 86.49%	125 $0
Q2 2021 Aug 16, 2021	SELL	$6.02 - $9.64 $4,816 - $7,712	-800 Reduced 46.38%	925 $7,000
Q1 2021 May 17, 2021	BUY	$9.17 - $14.8 $15,818 - $25,530	1,725 New	1,725 $16,000

66.2K

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

Get notified when there are updates to the investment portfolio of Eaton Vance Management, based on Form 13F filings with the SEC.

Stay updated on Eaton Vance Management with notifications on news.